Tirzepatide
A dual-agonist peptide that targets both the GLP-1 and GIP pathways for compounded weight management at SSK Longevity in Newport Beach, California.
A Dual-Pathway Approach to Metabolic Therapy
Tirzepatide is a synthetic peptide that activates two metabolic receptors at once: GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide). This dual-receptor mechanism distinguishes it from single-pathway peptides like semaglutide and is associated with stronger metabolic outcomes in clinical research.
At SSK Longevity in Newport Beach, tirzepatide is compounded under Sherry Kelishadi, Pharm.D.'s direct pharmacy oversight and prescribed under the supervision of Dr. Sean Kelishadi, MD FACS. Patients in Newport Beach, Costa Mesa, Irvine, and the broader Orange County area receive tirzepatide as part of a fully personalized metabolic protocol — not a one-size-fits-all weight loss prescription.
Why GLP-1 + GIP Outperforms Single-Receptor Therapy
Tirzepatide's dual-receptor design produces broader metabolic effects than GLP-1-only peptides. By engaging GIP simultaneously, it modulates appetite regulation, glucose handling, and energy storage through complementary pathways.
Appetite Regulation
GLP-1 activation slows gastric emptying and acts on hypothalamic satiety centers, reducing overall caloric intake without willpower-driven restriction.
Glucose & Insulin Response
Combined GLP-1 and GIP activity improves insulin sensitivity and glucose-dependent insulin release, addressing the metabolic root rather than calories alone.
Energy & Lipid Storage
GIP receptor activation in adipose tissue is associated with improved lipid metabolism and energy partitioning during weight reduction phases.
Compounded Tirzepatide, Calibrated to Your Physiology
Every tirzepatide protocol at SSK Longevity Newport Beach is compounded under Sherry Kelishadi, Pharm.D.'s direct review. Dose pacing, drug interaction screening, and complementary peptide layering are evaluated individually for each patient before any tirzepatide is dispensed.
Newport Beach, Irvine, and Costa Mesa patients receive a tirzepatide protocol calibrated to their physiology, comorbidities, and longevity goals — guided by lab work, not assumptions.
Individual results are not guaranteed and may vary from person to person.
- Personalized lab review and metabolic assessment
- Compounded under Pharm.D. supervision in Newport Beach
- Individualized dose protocols tailored to your physiology
- Drug interaction review before anything is dispensed
- Direct physician access throughout treatment
- Coordinated care with complementary protocols when appropriate
Peptides Compared To Or Layered With Tirzepatide
Patients pursuing tirzepatide in Newport Beach often layer or transition to these complementary peptide protocols for muscle preservation, metabolic depth, and long-term sustainability.
Peptide Therapy Stacked With Tirzepatide
Tirzepatide is rarely the whole protocol. SSK Longevity Newport Beach patients commonly layer peptide therapy alongside tirzepatide for muscle preservation, recovery, and metabolic depth. Sherry Kelishadi, Pharm.D. coordinates every combined protocol individually before dispensing.
Semaglutide
The single-receptor GLP-1 peer to tirzepatide. SSK Longevity patients often start with semaglutide before transitioning to tirzepatide for deeper metabolic effect.
Learn More →Retatrutide
Investigational triple-receptor agonist (GLP-1, GIP, and glucagon) showing the strongest weight loss outcomes in trials. Available off-label under physician supervision at SSK Longevity.
Learn More →CJC-1295 / Ipamorelin
Growth peptide stack used alongside tirzepatide for muscle preservation, recovery, and longevity layering.
Learn More →Tirzepatide Benefits at SSK Longevity in Newport Beach, CA
Tirzepatide therapy at SSK Longevity in Newport Beach produces deeper weight reduction, stronger glycemic control, and broader metabolic outcomes than single-receptor GLP-1 protocols. Our compounded Tirzepatide is designed by Dr. Sean Kelishadi, MD FACS and reviewed by Sherry Kelishadi, Pharm.D. for patients across Newport Beach, Costa Mesa, Irvine, Laguna Beach, Huntington Beach, Corona del Mar, and the broader Orange County area. Below are the dual-agonist clinical outcomes our Newport Beach Tirzepatide patients most consistently report.
Stronger Mean Weight Reduction
Clinical research shows tirzepatide produces greater average weight loss than GLP-1-only peptides, making it a preferred option for patients with significant weight loss goals.
Improved Insulin Sensitivity
Dual-receptor activity improves glucose handling and insulin response, addressing metabolic dysfunction rather than just weight.
Reduced Cravings & Appetite
Patients report sustained reduction in food noise and cravings throughout the dosing cycle, supporting long-term behavior change.
Cardiometabolic Markers
Improvements in blood pressure, lipid panels, and inflammatory markers are common alongside weight reduction in clinical research.
Sustained Energy & Stamina
Patients often describe steadier energy throughout the day as glucose regulation stabilizes and metabolic flexibility returns.
Plateau Resolution
Patients who plateau on semaglutide-class peptides frequently respond well to tirzepatide's broader mechanism.
Is Tirzepatide The Right Protocol For You?
Tirzepatide at SSK Longevity Newport Beach is appropriate for adults seeking medically supervised peptide therapy with physician oversight, lab-driven protocol design, and Pharm.D.-supervised compounding. Patients pursuing this protocol typically fit one or more of the profiles below.
Conditions Treated Alongside Tirzepatide in Newport Beach
How Tirzepatide Therapy Is Calibrated at SSK Longevity
Comprehensive Consultation
Lab review, medical history, and metabolic assessment with the SSK Longevity team in Newport Beach.
Personalized Protocol
Tirzepatide dose, titration pacing, and any complementary peptides are calibrated to your physiology and goals.
Pharmacist Compounding
Sherry Kelishadi, Pharm.D. oversees every compounded tirzepatide vial dispensed by SSK Longevity.
Ongoing Clinical Oversight
Scheduled follow-ups, lab rechecks, and dose adjustments calibrated to your response over time.
Tirzepatide Safety, Titration, and Contraindications
Tirzepatide therapy under proper medical supervision has a well-characterized safety profile, but real considerations deserve direct discussion before any Newport Beach patient begins a protocol.
-
—
Gastrointestinal side effects during titration Nausea, mild GI discomfort, and altered bowel habits are common, peaking in the first weeks and improving with proper dose pacing.
-
—
Muscle preservation requires active attention Deeper weight loss creates risk of significant lean mass loss. Resistance training, adequate protein, and complementary peptides are integrated into every protocol.
-
—
Contraindicated in MTC or MEN2 history Tirzepatide is not appropriate for patients with personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Screened during initial consultation.
-
—
Pancreatitis risk requires monitoring Rare but serious. Patients with prior pancreatitis are typically not candidates. Persistent severe abdominal pain warrants immediate evaluation.
-
—
Not appropriate during pregnancy or breastfeeding Tirzepatide should be discontinued well in advance of planned pregnancy. Adequate contraception is required during treatment in patients of reproductive age.
-
—
Long-term sustainability planning Weight regain is common after discontinuation if no maintenance strategy is in place. Exit strategies and maintenance protocols are discussed upfront.
What patients actually say.
"Tirzepatide was the first thing that actually moved the needle for me. The team at SSK was meticulous about my labs and dosing."
"I'd plateaued for months on another peptide. Switching to compounded tirzepatide under Sherry's oversight got me past it."
"What I appreciated most was the lab-driven approach. Nothing was prescribed without my full metabolic picture."
From Our Founders
Tirzepatide's dual-receptor mechanism produces metabolic results we simply did not see with single-pathway peptides. For the right patient, the difference is significant — and that's why patient selection and lab-driven protocol design matter so much.
Every tirzepatide vial we dispense at SSK Longevity is reviewed individually for dose accuracy, drug interactions, and titration pacing. Compounded medications require this level of pharmacist involvement; it should never be one-size-fits-all.
Why Tirzepatide Patients Choose SSK Longevity
Tirzepatide FAQ for Newport Beach & Orange County
How is tirzepatide different from semaglutide?
Tirzepatide activates both GLP-1 and GIP receptors, while semaglutide activates only GLP-1. The dual-receptor mechanism is associated with stronger weight loss outcomes and improved insulin sensitivity in clinical research.
Is compounded tirzepatide FDA-approved?
Tirzepatide is FDA-approved as a branded prescription medication. Compounded versions of tirzepatide may be prescribed under physician supervision in specific clinical circumstances and are not FDA-approved formulations.
How long is a typical tirzepatide protocol at SSK Longevity?
Protocol length is individualized based on your goals, response, and lab markers. Most patients commit to a structured titration phase followed by a maintenance approach calibrated to their metabolic response.
Can I switch from semaglutide to tirzepatide?
Many SSK Longevity patients transition from semaglutide to tirzepatide after plateauing or when seeking deeper metabolic effect. Transition timing and dosing are evaluated individually.
What labs are required before starting?
A comprehensive metabolic panel, hemoglobin A1c, lipid panel, thyroid markers, and other relevant labs are reviewed before initiation. Sean and Sherry tailor the workup to your medical history.
Will I need to follow a specific diet?
Tirzepatide works alongside reasonable nutrition and protein intake — especially to preserve lean mass during weight loss. Specific guidance is provided during your consultation.
How is tirzepatide layered with peptide therapy?
Many patients combine tirzepatide with growth peptides like CJC-1295/Ipamorelin for muscle preservation during weight loss. Layering is always reviewed individually for safety and clinical fit.
Where is SSK Longevity located?
SSK Longevity is in Newport Beach, California, at 500 Superior Avenue, Suite 340 — serving patients across Orange County including Costa Mesa, Irvine, Huntington Beach, and Laguna Beach.
Treatments Stacked With Tirzepatide at SSK Longevity
Tirzepatide is FDA-approved as a branded prescription medication. Compounded versions of tirzepatide may be prescribed under physician supervision in specific clinical circumstances, and compounded formulations are not FDA-approved. The information on this page is for educational purposes only and does not constitute medical advice. Treatment requires physician evaluation, comprehensive laboratory testing, and ongoing clinical oversight. Compounded peptide therapy is generally an out-of-pocket service and is not typically covered by insurance. Payment options and financing are available. Individual results are not guaranteed and may vary from person to person. All treatments are administered under the supervision of a licensed physician.